PRDM12 is a Krüppel-like zinc finger transcriptional regulator essential for nociceptor development and pain perception. During neurogenesis, PRDM12 initiates differentiation of nociceptive neurons from neural crest progenitors by activating downstream pro-neuronal transcription factors including NEUROD1, BRN3A, and ISL1, while simultaneously repressing non-nociceptor cell fates 1. Loss of PRDM12 during development results in complete absence of the nociceptive lineage, causing congenital insensitivity to pain 2. In mature nociceptors, PRDM12 expression persists but serves a distinct function—regulating gene expression networks encoding ion channels and receptors that modulate neuronal excitability and pain-related behavior 3. Adult Prdm12-deficient mice show altered responses to inflammatory pain stimuli but maintain basic thermal and mechanical nociception 4. PRDM12 mutations cause hereditary sensory and autonomic neuropathy type VIII (HSAN8), characterized by inability to perceive pain, temperature sensation defects, and self-injury due to absent nociception 5. Beyond neurobiology, emerging evidence indicates PRDM12 functions as an epigenetic checkpoint regulating CD8+ T cell effector differentiation and anti-tumor immunity, suggesting broader neuroimmune regulatory roles 6. These findings position PRDM12 as both a critical developmental determinant and a potential therapeutic target for pain disorders.